D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOTV
3801
DELISTED
Inotiv
NOTV
| $318K | ﹤0.01% |
187,079
+39,200
| +27% | +$66.3K |
|
|
LPRO
3802
Open Lending Corp
LPRO
$372M
| $317K | ﹤0.01% |
51,762
-28,039
| -35% | -$161K |
|
|
APLT
3803
DELISTED
Applied Therapeutics
APLT
| $316K | ﹤0.01% |
+37,235
| New | +$219K |
|
|
CGC
3804
Canopy Growth
CGC
$390M
| $315K | ﹤0.01% |
65,407
+50,930
| +352% | +$308K |
|
3805
PUT
Annaly Capital Management
NLY
$16.9B
| $315K | ﹤0.01% |
+15,700
| New | +$314K |
|
|
MRNS
3806
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $315K | ﹤0.01% |
+178,801
| New | +$250K |
|
3807
Cato Corp
CATO
$64.1M
| $315K | ﹤0.01% |
63,061
+24,001
| +61% | +$118K |
|
3808
Corpay
CPAY
$24.8B
| $315K | ﹤0.01% |
1,006
-2,095
| -68% | -$615K |
|
3809
PUT
Beazer Homes USA
BZH
$903M
| $314K | ﹤0.01% |
+9,200
| New | +$283K |
|
3810
iShares US Healthcare ETF
IYH
$3.38B
| $314K | ﹤0.01% |
4,831
-1,129
| -19% | -$72.1K |
|
3811
iShares MSCI USA Equal Weighted ETF
EUSA
$1.82B
| $313K | ﹤0.01% |
+3,274
| New | +$299K |
|
|
TERN
3812
DELISTED
Terns Pharmaceuticals
TERN
| $313K | ﹤0.01% |
37,471
+10,506
| +39% | +$86.4K |
|
3813
CALL
Tapestry
TPR
$29.8B
| $310K | ﹤0.01% |
6,600
-131,700
| -95% | -$5.43M |
|
3814
Essential Properties Realty Trust
EPRT
$6.9B
| $309K | ﹤0.01% |
+9,057
| New | +$280K |
|
|
CALY
3815
Callaway Golf Company
CALY
$3.28B
| $309K | ﹤0.01% |
+28,129
| New | +$354K |
|
3816
Surgery Partners
SGRY
$1.98B
| $307K | ﹤0.01% |
9,537
-147,732
| -94% | -$4.36M |
|
3817
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.03B
| $307K | ﹤0.01% |
+6,657
| New | +$271K |
|
3818
Olema Pharmaceuticals
OLMA
$1.05B
| $306K | ﹤0.01% |
25,593
+4,534
| +22% | +$58K |
|
3819
Fresenius Medical Care
FMS
$13.4B
| $305K | ﹤0.01% |
+14,340
| New | +$282K |
|
3820
AngloGold Ashanti
AU
$40.7B
| $305K | ﹤0.01% |
11,452
-19,390
| -63% | -$557K |
|
3821
NewAmsterdam Pharma
NAMS
$3.53B
| $305K | ﹤0.01% |
+18,345
| New | +$317K |
|
3822
Vanguard Russell 1000 Value ETF
VONV
$20.5B
| $304K | ﹤0.01% |
3,646
-18,341
| -83% | -$1.47M |
|
3823
Vanguard Russell 1000 Growth ETF
VONG
$42.3B
| $303K | ﹤0.01% |
+3,142
| New | +$293K |
|
|
DCH
3824
Dauch Corp
DCH
$1.32B
| $303K | ﹤0.01% |
48,990
-120,415
| -71% | -$784K |
|
3825
Harmony Gold Mining
HMY
$9.92B
| $302K | ﹤0.01% |
29,710
+15,713
| +112% | +$153K |
|
Similar funds
D.E. Shaw & Co's Q3 2024 Portfolio in Review
As of Q3 2024, D.E. Shaw & Co held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- D.E. Shaw & Co added most to NVIDIA in Q3 2024, an estimated $708M increase.
- D.E. Shaw & Co's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- D.E. Shaw & Co fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- D.E. Shaw & Co opened 599 new positions and closed 558 in Q3 2024.
- D.E. Shaw & Co's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.